Viome Life Sciences initiated a collaboration with Scripps Research to validate a stool-based colorectal polyp detection test that employs RNA sequencing and artificial intelligence algorithms. This test aims to identify precancerous polyps non-invasively and improve screening coverage for patients ineligible or unwilling to undergo colonoscopies. The study will recruit 1,000 patients undergoing screening colonoscopies at Scripps Health, aiming to refine predictive biomarker signatures by integrating microbiome and host immune response data. Positive results could lead to a commercial launch and enhanced early detection capabilities.